Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Tiemersma, Edinevan den Hof, Susan
Dravniece, Gunta
Wares, Fraser
Molla, Yohannes
Permata, Yusie
Lukitosari, Endang
Quelapio, Mamel
Aung, Si Thu
Aung, Khay Mar
Thuy, Hoang Thanh
Hoa, Vu Dinh
Sulaimanova, Merkinai
Sagyndikova, Saadat
Makhmudova, Mavluda
Soliev, Alijon
Kimerling, Michael
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.Published in
Eur Respir Rev 2019; 28(153):pii.108115PMID
31604816ae974a485f413a2113503eed53cd6c53
10.1183/16000617.0115-2018
Scopus Count
Collections
Related articles
- Setting up pharmacovigilance based on available endTB Project data for bedaquiline.
- Authors: Lachenal N, Hewison C, Mitnick C, Lomtadze N, Coutisson S, Osso E, Ahmed S, Leblanc G, Islam S, Atshemyan H, Nair P, Kholikulov B, Aiylchiev S, Zarli K, Adnan S, Krisnanda A, Padayachee S, Stambekova A, Sahabutdinova Y, de Guadalupe S, Moreno P, Kumsa A, Reshid A, Makaka J, Abebe S, Melikyan N, Seung KJ, Khan U, Khan P, Huerga H, Rich M, Varaine F
- Issue date: 2020 Oct 1
- Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance.
- Authors: Jaber AAS, Ibrahim B
- Issue date: 2019 May 24
- Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis.
- Authors: Tiemersma EW, Ali I, Alemu A, Avong YK, Duga A, Elagbaje C, Isah A, Kay A, Mmbaga BT, Mmari E, Mwamwitwa K, Nhlabatsi S, Sintayehu K, Arefayne A, Teferi M, Cobelens F, Härmark L
- Issue date: 2021 Oct 8
- Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
- Authors: Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Cadiñanos Loidi J, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Escobar Salinas N, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Gomez Rosso R, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Martínez Robles E, Matteelli A, Mazza-Stalder J, Moschos C, Muñoz-Torrico M, Mustafa Hamdan H, Nakčerienė B, Nicod L, Nieto Marcos M, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB
- Issue date: 2019 Dec
- "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
- Authors: Jakasania A, Shringarpure K, Kapadia D, Sharma R, Mehta K, Prajapati A, Kathirvel S
- Issue date: 2020 Dec 2